Novo Nordisk logo

Novo Nordisk

NVO | NYSE
Chart Builder DCF Calculator
$41.60
-$0.03 (-0.07%)
At close: Nov 16, 2026, 4:00 PM ET
$41.55
-$0.05 (-0.12%)
After-hours: Nov 16, 2026, 7:56 PM ET
-0.07%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
63.8
-0.2 pts
Fundamentals Strong
Market Sentiment Neutral
Moat Wide
Sector Rank #104/1021 (Top 10%)

Why Price Moved

7 days ago
+2.65%

Shares are trading higher after the company report...

Key Statistics

Market Data

Market Cap $183.39B
1D Range
41.44 42.30
52W Range
35.29 63.98

Valuation (TTM)

PE 10.52
PB 5.56
EV/EBITDA 7.00

Valuation (NTM)

Forward PE 12.28
Forward PEG -4.37
Price Target $40.00
Loading financial charts...

Profile

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market prese...

Sector Healthcare
Employees 68,794
IPO Date Apr 30, 1981
Fiscal Year January - December

Latest News

NVO's Hemophilia A Treatment Gets EC Nod, Data Presented on CagriSema

12 hours ago · zacks.com

NVO's Hemophilia A Treatment Gets EC Nod, Data Presented on CagriSema
Novo Nordisk Shares Rise on Positive Weight-Loss Data, Hemophilia Drug Approval

17 hours ago · wsj.com

Novo Nordisk Shares Rise on Positive Weight-Loss Data, Hemophilia Drug Approval
Novo's Wegovy pill helps patients lose about 6% of weight in three months, real-world data show

2 days ago · reuters.com

Novo's Wegovy pill helps patients lose about 6% of weight in three months, real-world data show
Blackstone Is Paying Up to $1.5 Billion for Pfizer’s Answer to Wegovy

4 days ago · 247wallst.com

Blackstone Is Paying Up to $1.5 Billion for Pfizer’s Answer to Wegovy
Novo and DJ Khaled team up to take fans behind the scenes of the iconic musician's real-life "Walk, Golf, and Wegovy®" diet and weight-loss routine

4 days ago · prnewswire.com

Novo and DJ Khaled team up to take fans behind the scenes of the iconic musician's real-life "Walk, Golf, and Wegovy®" diet and weight-loss routine
SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For November 2026

4 days ago · seekingalpha.com

SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For November 2026
Novo Nordisk: Better Than It Looks, But Not A Buy Yet

4 days ago · seekingalpha.com

Novo Nordisk: Better Than It Looks, But Not A Buy Yet
JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?

5 days ago · fool.com

JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?
Novo Nordisk: Valuations Are Blind To The Upside

5 days ago · seekingalpha.com

Novo Nordisk: Valuations Are Blind To The Upside
Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady

6 days ago · 247wallst.com

Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.89
Beat +21.75%
REV
$11.9B
Beat +7.54%
Next Earnings
Feb 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Hold
Price Target
$40.00
Downside
-3.85%
Buy (0)
Hold (5)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.